Effect of shRNA targeting survivin on ovarian cancer

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 7, 2012, Pages 1221-1229

  Xing, Jun ^a   Jia, Chang Ru ^a   Wang, Yan ^a   Guo, Jing ^b   Cai, Yan ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Jian Hua Hospital Jian Hua District   (China)

Author keywords

Apoptosis; Cisplatin; Matrix metalloproteinase 2; Ovarian cancer; RNA interference; SKOV3 cells; Survivin; Tissue inhibitor of metalloproteinase 1

Indexed keywords

SHORT HAIRPIN RNA; SURVIVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG TARGETING; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, NUDE; MICROSCOPY, ELECTRON, TRANSMISSION; OVARIAN NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84864359992     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-012-1196-0     Document Type: Article

References (29)

1. Altieri DC (2010) Survivin and IAP proteins in cell-death mechanisms. Biochem J 430:199-205
2. Anne TM, Taina TH (2010) Levels of Circulating TIMP-2 and MMP2-TIMP2 Complex Are Decreased in Squamous Cervical Carcinoma. Obstet Gynecol Int. doi:10.1155/2010/179351
3. Deng KX, Zhong L, Jiang MX, Wang PL, Chen Y (2005a) RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM. Zhonghua Fu Chan Ke Za Zhi 40:836-839 [Chinese]
4. Deng KX, Zhong L, Jiang MX, Chen WX, Chen Y, He H (2005b) Effect of RNAi-mediated survivin gene silencing on apoptosis of ovarian cancer cell lines SKOV3 and SKOV3/ADM. Ai Zheng 24:945-950 [Chinese]
5. Dutta A, Sen T, Banerji A, Das S, Chatterjee A (2009) Studies on multifunctional effect of all-trans retinoic acid (ATRA) on matrix metalloproteinase-2 (MMP-2) and its regulatory molecules in human breast cancer cells (MCF-7). J Oncol. doi: 10.1155/2009/627840
6. Gong YI, Xu GM, Huang WD (2000) Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer. J Surg Oncol 73:95-99 (Pubitemid 30123732)
7. Hanemaaier R, Verheijen JH, Mayuire TM, Visser H, Toet K, McDermott E, O'Higgins N, Duffy MJ (2000) Increased gelatinase-A and gelatinase-B activities in malignant vs benign breast tumors. Int J Cancer 86:204-207 (Pubitemid 30180815)
8. Ikeguchi M, Kaibara N (2001) Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer. Int J Mol Med 8:661-666
9. Ikeguchi M, Liu J, Kaibara N (2002) Expression of surviving mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment. Apoptosis 7:23-29 (Pubitemid 34145388)
10. Jiang X, Wilford C, Duensing S, Munger K, Jones G, Jones D (2001) Participation of Survivin in mitotic and apoptotic activities of normal and tumor-derived cells. J Cell Biochem 83:342-354 (Pubitemid 32896603)
11. Johnson AL, Langer JS, Bridgham JT (2002) Survivin as a cell cyclerelated and antiapoptotic protein in granulosa cells. Endocrinology 143:3405-3413 (Pubitemid 34925715)
12. Kahari VM, Saarialho-Kere U (1999) Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 31:34-45 (Pubitemid 29134483)
13. Li G, Xie B, Li X, Chen Y, Wang Q, Xu Y, Xu-Welliver M, Zou L (2012) Down-regulation of survivin and Hypoxia-Inducible Factor-1a by b-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft. Cancer Biother Radiopharm. [PMID: 22248028, Epub ahead of print]
14. Liu Q, Fu H, Xing R, Tie Y, Zhu J, Sun Z, Zheng X (2008) Survivin knockdown combined with apoptin overexpression inhibits cell growth significantly. Cancer Biol Ther 7:1053-1060
15. Lukaszewicz-Zajac M, Mroczko B, Szmitkowski M (2009) The significance of metalloproteinases and their inhibitors in gastric cancer. Postepy Hig Med Dosw 63:258-265
16. McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, Clarke-Pearson DL, Davidson M (1996) Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N Engl J Med 334:1-6 (Pubitemid 26012496)
17. Mroczko B, Groblewska M, Okulczyk B, Kedra B, Szmitkowski M (2010) The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients. Int J Colorectal Dis 25:1177-1184
18. Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J, Breathnach R (1994) The collagenase gene family in humans consists of at least four members. Biochem J 253:187-192
19. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) Matrix metalloproteinase: biologic activity and clinical implication. J Clin Oncol 18:1135-11491
20. Pecot CV, Calin GA, Coleman RL, Lopez-Berestein G, Sood AK (2011) RNA interference in the clinic: challenges and future directions. Nat Rev Cancer 11:59-67
21. Posadas EM, Davidson B, Kohn EC (2004) Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review the recent literature. Curr Opin Oncol 16:478-484 (Pubitemid 39159178)
22. Shen J, Liu J, Long Y, Miao Y, Su M, Zhang Q, Han H, Hao X (2009) Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity. Acta Biochim Biophys Sin (Shanghai) 41:223-230
23. Vivas-Mejia PE, Rodriguez-Aguayo C, Han HD, Shahzad MM, Valiyeva F, Shibayama M, Chavez-Reyes A, Sood AK, Lopez- Berestein G (2011) Silencing survivin splice variant 2B leads to antitumor activity in taxane-resistant ovarian cancer. Clin Cancer Res 17:3716-3726
24. Vu TH, Werb Z (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14:2123-2133
25. Yamamoto H, Ngan CY, Monden M (2008) Cancer cells survive with survivin. Cancer Sci 99:1709-1714
26. Ye S, Humphries S, Henney A (1998) Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis. Clin Sci 94:103-110 (Pubitemid 28052639)
27. Zhang X, Li N, Wang YH, Huang Y, Xu NZ, Wu LY (2009) Effects of survivin siRNA on growth, apoptosis and chemosensitivity of ovarian cancer cells SKOV3/DDP. Zhonghua Zhong Liu Za Zhi 31:174-177 [Chinese]
28. Zhen HN, Li LW, Zhang W, Fei Z, Shi CH, Yang TT, Bai WT, Zhang X (2007) Short hairpin RNA targeting survivin inhibits growth and angiogenesis of glioma U251 cells. Int J Oncol 31:1111-1117
29. Zhou J, Gan N, Zhang W, Lu W, Xie X (2010) Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor. J Obstet Gynaecol Res 36:232-238